241 results
Page 3 of 13
8-K
EX-99.1
s6408hkqscwckug b051
9 Nov 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
oewqv80x165b1d9po
20 Oct 21
Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors
9:13am
8-K
lfopi2pd5a4i
14 Sep 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
2uh0hgoeu
14 Sep 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
gag8nzsb zva6sgm6dm0
10 Sep 21
Other Events
6:01am
424B5
c1wkamu053io5wyycg2l
13 Aug 21
Prospectus supplement for primary offering
5:08pm
8-K
EX-99.1
jkldjr cw5e
12 Aug 21
Humanigen Reports Second Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
54mzd55nqaet9k
4 Aug 21
Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients
6:04am
8-K
EX-99.2
tsk2a9zf uzifcqkvvl
4 Aug 21
Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients
6:04am
8-K
b1f7x4rv2gd8v 90c
4 Aug 21
Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients
6:04am
8-K
EX-99.1
fckh6n
14 Jul 21
Regulation FD Disclosure
11:58am
8-K
6943pg7
14 Jul 21
Regulation FD Disclosure
11:58am
8-K
EX-99.1
78e8tke
17 Jun 21
Humanigen 2021 Annual Stockholder Meeting June 17
6:30am
8-K
2hxwackza ewh
17 Jun 21
Humanigen 2021 Annual Stockholder Meeting June 17
6:30am
8-K
EX-99.1
1gjc97iz
28 May 21
Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19
5:00pm